Briarcliff Manor, NY, United States of America

Shao-Chun Wang

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shao-Chun Wang. Retrieved from https://idiyas.com/inventor/shao-chun-wang-vfg8mf2f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Shao-Chun Wang

Introduction

Shao-Chun Wang is a notable inventor based in Briarcliff Manor, NY (US). He has made significant contributions to the field of protein analysis, particularly through his innovative methods for studying glycosylated proteins. His work is essential for advancing our understanding of post-translational modifications in proteins.

Latest Patents

Shao-Chun Wang holds a patent titled "Deglycosylation methods for electrophoresis of glycosylated proteins." This patent relates to methods of analyzing a post-translationally modified protein of interest using electrophoresis. The methods involve deglycosylating the protein of interest after labeling, which enhances the accuracy of protein analysis.

Career Highlights

Shao-Chun Wang is currently employed at Regeneron Pharmaceuticals, Inc., where he applies his expertise in protein analysis to contribute to the company's research and development efforts. His work at Regeneron is pivotal in the advancement of therapeutic solutions.

Collaborations

Shao-Chun Wang collaborates with talented colleagues, including Yiming Zhao and Hunter Chen. These collaborations foster a dynamic research environment that encourages innovation and the sharing of ideas.

Conclusion

Shao-Chun Wang's contributions to the field of protein analysis through his innovative patent and work at Regeneron Pharmaceuticals highlight his importance as an inventor. His methods for analyzing glycosylated proteins are paving the way for future advancements in biochemistry and therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…